Inogen Revenue and Competitors
Estimated Revenue & Valuation
- Inogen's estimated annual revenue is currently $355.6M per year.
- Inogen's estimated revenue per employee is $451,244
- Inogen's total funding is $73.3M.
- Inogen's current valuation is $699.9M. (January 2022)
Employee Data
- Inogen has 788 Employees.
- Inogen grew their employee count by -3% last year.
Inogen's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Innovation Strategy | Reveal Email/Phone |
2 | SVP Investor Relations & Strategic Planning | Reveal Email/Phone |
3 | EVP, General Counsel | Reveal Email/Phone |
4 | VP, Organizational Effectiveness, Learning, and Development | Reveal Email/Phone |
5 | VP Consumer Marketing | Reveal Email/Phone |
6 | VP, B2B Business, US and Canada | Reveal Email/Phone |
7 | SVP, Operations and Supply Chain | Reveal Email/Phone |
8 | VP, Marketing and Porfolio | Reveal Email/Phone |
9 | VP Engineering | Reveal Email/Phone |
10 | SVP Enterprise Enablement and Patient Services | Reveal Email/Phone |
Inogen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.2M | 47 | 4% | N/A | N/A |
#2 | $57.5M | 229 | 6% | N/A | N/A |
#3 | $19670M | 176108 | N/A | N/A | $30.3B |
What Is Inogen?
Inogen's mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae's Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. We believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. With each step we take to improve our products and service, our customers take another step toward more freedom.
keywords:N/A$73.3M
Total Funding
788
Number of Employees
$355.6M
Revenue (est)
-3%
Employee Growth %
$699.9M
Valuation
N/A
Accelerator
Inogen News
Inogen (NASDAQ:INGN Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, May 5th.
Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at:...
Inspired by Mae, a grandmother with COPD who complained about the restrictiveness of oxygen therapywhich required switching tanks and carrying...
GOLETA, Calif. — Inogen, Inc. (Nasdaq:INGN) announced today that it has received FDA clearance for an innovative home oxygen concentrator called the Inogen At Home. The Inogen At Home is expected to be the lightest 5 liter per minute continuous flow oxygen concentrator on the market, when it is ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $485.9M | 1718 | 5% | N/A |
#2 | $1026.8M | 5058 | N/A | N/A |
#3 | $2870M | 5979 | 10% | N/A |
#4 | $8630M | 20576 | 5% | N/A |